Switch theme
Sign up to access all valuation multiples
Cogstate Ltd is a cognitive science company. The principal activity of the group is Creation, validation and commercialisation of digital brain health assessments; and Design and provision of quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
1999
352
LTM Revenue $80.9M
LTM EBITDA $22.8M
$159M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cogstate has a last 12-month revenue (LTM) of $80.9M and a last 12-month EBITDA of $22.8M.
In the most recent fiscal year, Cogstate achieved revenue of $28.4M and an EBITDA of $6.5M.
Cogstate expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cogstate valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $80.9M | XXX | $28.4M | XXX | XXX | XXX |
| Gross Profit | $53.1M | XXX | $16.1M | XXX | XXX | XXX |
| Gross Margin | 66% | XXX | 57% | XXX | XXX | XXX |
| EBITDA | $22.8M | XXX | $6.5M | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 23% | XXX | XXX | XXX |
| EBIT | $18.6M | XXX | $4.0M | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $14.2M | XXX | $3.6M | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 13% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 1, 2025, Cogstate's stock price is AUD 2 (or $1).
Cogstate has current market cap of AUD 295M (or $193M), and EV of AUD 243M (or $159M).
See Cogstate trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $159M | $193M | XXX | XXX | XXX | XXX | $0.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 1, 2025, Cogstate has market cap of $193M and EV of $159M.
Cogstate's trades at 3.9x EV/Revenue multiple, and 14.9x EV/EBITDA.
Equity research analysts estimate Cogstate's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cogstate has a P/E ratio of 20.8x.
See valuation multiples for Cogstate and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $193M | XXX | $193M | XXX | XXX | XXX |
| EV (current) | $159M | XXX | $159M | XXX | XXX | XXX |
| EV/Revenue | 3.0x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBITDA | 10.7x | XXX | 14.9x | XXX | XXX | XXX |
| EV/EBIT | 13.1x | XXX | 19.7x | XXX | XXX | XXX |
| EV/Gross Profit | 4.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 20.8x | XXX | 30.0x | XXX | XXX | XXX |
| EV/FCF | 13.9x | XXX | 22.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCogstate's last 12 month revenue growth is 11%
Cogstate's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $34K for the same period.
Cogstate's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cogstate's rule of X is 57% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cogstate and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 15% | XXX | 77% | XXX | XXX | XXX |
| Rule of 40 | 30% | XXX | 38% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 57% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $34K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 43% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
| Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
| Vidavo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cogstate acquired XXX companies to date.
Last acquisition by Cogstate was XXXXXXXX, XXXXX XXXXX XXXXXX . Cogstate acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cogstate founded? | Cogstate was founded in 1999. |
| Where is Cogstate headquartered? | Cogstate is headquartered in Australia. |
| How many employees does Cogstate have? | As of today, Cogstate has 352 employees. |
| Is Cogstate publicy listed? | Yes, Cogstate is a public company listed on ASX. |
| What is the stock symbol of Cogstate? | Cogstate trades under CGS ticker. |
| When did Cogstate go public? | Cogstate went public in 2004. |
| Who are competitors of Cogstate? | Similar companies to Cogstate include e.g. Beamtree, Echo IQ, Impedimed, Proteomics International. |
| What is the current market cap of Cogstate? | Cogstate's current market cap is $193M |
| What is the current revenue of Cogstate? | Cogstate's last 12 months revenue is $80.9M. |
| What is the current revenue growth of Cogstate? | Cogstate revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Cogstate? | Current revenue multiple of Cogstate is 3.0x. |
| Is Cogstate profitable? | Yes, Cogstate is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cogstate? | Cogstate's last 12 months EBITDA is $22.8M. |
| What is Cogstate's EBITDA margin? | Cogstate's last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of Cogstate? | Current EBITDA multiple of Cogstate is 10.7x. |
| What is the current FCF of Cogstate? | Cogstate's last 12 months FCF is $17.5M. |
| What is Cogstate's FCF margin? | Cogstate's last 12 months FCF margin is 22%. |
| What is the current EV/FCF multiple of Cogstate? | Current FCF multiple of Cogstate is 13.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
